Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

Saved in:

Bibliographic Details
Published in:	Bone marrow transplantation (Basingstoke) Vol. 56; no. 3; pp. 745 - 748
Main Authors:	Sheshadri, Ajay, Saliba, Rima, Patel, Badar, Ahmed, Tahreem, Bueno, Luis C., Arain, Muhammad H., Mehta, Rohtesh S., Popat, Uday R., Hosing, Chitra M., Rondon, Gabriela, Bashoura, Lara, Dickey, Burton F., Champlin, Richard E., Alousi, Amin M.
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-03-2021 Nature Publishing Group
Subjects:	692/308/174 692/700/565/2194 Antibiotics Antithymocyte globulin Azithromycin Cancer Cell Biology Complications and side effects Correspondence Globulins Graft versus host reaction Hematology Hematopoietic stem cells Internal Medicine Lung diseases Medicine Medicine & Public Health Patient outcomes Public Health Relapse Risk factors Stem cell transplantation Stem Cells Thymocytes Transplantation United States
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0268-3369 1476-5365
DOI:	10.1038/s41409-020-01073-0